NHI 📈 National Health Investors - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US63633D1046
NHI: Senior Housing, Nursing Facilities, Hospitals, Retirement Communities
Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals. Web URL: https://www.nhireit.com
Additional Sources for NHI Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NHI Stock Overview
| Market Cap in USD | 3,482m |
| Sector | Real Estate |
| Industry | REIT - Healthcare Facilities |
| GiC Sub-Industry | Health Care REITs |
| IPO / Inception | 1991-10-09 |
NHI Stock Ratings
| Growth 5y | 31.4% |
| Fundamental | 11.4% |
| Dividend | 39.5% |
| Rel. Strength Industry | 358 |
| Analysts | 3.88/5 |
| Fair Price Momentum | 65.22 USD |
| Fair Price DCF | 111.39 USD |
NHI Dividends
| Dividend Yield 12m | 5.15% |
| Yield on Cost 5y | 6.10% |
| Annual Growth 5y | -3.04% |
| Payout Consistency | 93.8% |
NHI Growth Ratios
| Growth Correlation 3m | -72.7% |
| Growth Correlation 12m | 90.6% |
| Growth Correlation 5y | 37.1% |
| CAGR 5y | 3.41% |
| CAGR/Mean DD 5y | 0.15 |
| Sharpe Ratio 12m | 1.14 |
| Alpha | -5.22 |
| Beta | 1.42 |
| Volatility | 31.74% |
| Current Volume | 780.4k |
| Average Volume 20d | 295.8k |
What is the price of NHI stocks?
As of December 21, 2024, the stock is trading at USD 69.85 with a total of 780,418 shares traded.
Over the past week, the price has changed by -4.00%, over one month by -9.45%, over three months by -15.14% and over the past year by +29.57%.
As of December 21, 2024, the stock is trading at USD 69.85 with a total of 780,418 shares traded.
Over the past week, the price has changed by -4.00%, over one month by -9.45%, over three months by -15.14% and over the past year by +29.57%.
Is National Health Investors a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, National Health Investors is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 11.42 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NHI as of December 2024 is 65.22. This means that NHI is currently overvalued and has a potential downside of -6.63%.
Neither. Based on ValueRay Fundamental Analyses, National Health Investors is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 11.42 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NHI as of December 2024 is 65.22. This means that NHI is currently overvalued and has a potential downside of -6.63%.
Is NHI a buy, sell or hold?
National Health Investors has received a consensus analysts rating of 3.88. Therefor, it is recommend to buy NHI.
National Health Investors has received a consensus analysts rating of 3.88. Therefor, it is recommend to buy NHI.
- Strong Buy: 3
- Buy: 1
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecast for NHI stock price target?
According to ValueRays Forecast Model, NHI National Health Investors will be worth about 72.4 in December 2025. The stock is currently trading at 69.85. This means that the stock has a potential upside of +3.68%.
According to ValueRays Forecast Model, NHI National Health Investors will be worth about 72.4 in December 2025. The stock is currently trading at 69.85. This means that the stock has a potential upside of +3.68%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 85 | 21.7% |
| Analysts Target Price | 54.9 | -21.5% |
| ValueRay Target Price | 72.4 | 3.7% |